Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 21470131)

1.

Epithelial-mesenchymal transition: implications in cancer progression and metastasis.

Gomes LR, Terra LF, Sogayar MC, Labriola L.

Curr Pharm Biotechnol. 2011 Nov;12(11):1881-90. Review.

PMID:
21470131
2.

Epithelial-mesenchymal transition and the invasive potential of tumors.

Gavert N, Ben-Ze'ev A.

Trends Mol Med. 2008 May;14(5):199-209. doi: 10.1016/j.molmed.2008.03.004. Epub 2008 Apr 10.

PMID:
18406208
3.

[Encounter of cancer cells with bone. Epithelial-mesenchymal transition in cancer].

Horiguchi K, Saitoh M.

Clin Calcium. 2011 Mar;21(3):405-10. doi: CliCa1103405410. Review. Japanese.

PMID:
21358062
4.

The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis.

Meng F, Wu G.

Cancer Metastasis Rev. 2012 Dec;31(3-4):455-67. doi: 10.1007/s10555-012-9379-3. Review.

PMID:
22733307
5.

The role of epithelial-mesenchymal transition in cancer pathology.

Guarino M, Rubino B, Ballabio G.

Pathology. 2007 Jun;39(3):305-18. Review.

PMID:
17558857
6.

MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression.

Bullock MD, Sayan AE, Packham GK, Mirnezami AH.

Biol Cell. 2012 Jan;104(1):3-12. doi: 10.1111/boc.201100115. Epub 2011 Dec 9. Review.

PMID:
22188537
7.

Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.

Sabbah M, Emami S, Redeuilh G, Julien S, Prévost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C.

Drug Resist Updat. 2008 Aug-Oct;11(4-5):123-51. doi: 10.1016/j.drup.2008.07.001. Epub 2008 Aug 20. Review.

PMID:
18718806
8.

Induction of epithelial-mesenchymal transition by transforming growth factor β.

Moustakas A, Heldin CH.

Semin Cancer Biol. 2012 Oct;22(5-6):446-54. doi: 10.1016/j.semcancer.2012.04.002. Epub 2012 Apr 23. Review.

PMID:
22548724
9.

Is the epithelial-to-mesenchymal transition clinically relevant for the cancer patient?

Krasnapolski MA, Todaro LB, de Kier Joffé EB.

Curr Pharm Biotechnol. 2011 Nov;12(11):1891-9. Review.

PMID:
21470129
10.

SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.

Wu YY, Peck K, Chang YL, Pan SH, Cheng YF, Lin JC, Yang RB, Hong TM, Yang PC.

Oncogene. 2011 Aug 25;30(34):3682-93. doi: 10.1038/onc.2011.85. Epub 2011 Mar 28.

PMID:
21441952
11.

Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development.

Orlichenko LS, Radisky DC.

Clin Exp Metastasis. 2008;25(6):593-600. doi: 10.1007/s10585-008-9143-9. Epub 2008 Feb 20. Review.

PMID:
18286378
12.

TGF-β in epithelial to mesenchymal transition and metastasis of liver carcinoma.

Reichl P, Haider C, Grubinger M, Mikulits W.

Curr Pharm Des. 2012;18(27):4135-47. Review.

PMID:
22630087
13.

[Epithelial-mesenchymal transition in cancer progression].

Gos M, Miłoszewska J, Przybyszewska M.

Postepy Biochem. 2009;55(2):121-8. Review. Polish.

PMID:
19824467
14.

Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis.

Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H, Mikulits W.

Mutat Res. 2004 Jan;566(1):9-20. Review.

PMID:
14706509
15.

HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.

Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH, Moustakas A.

J Biol Chem. 2008 Nov 28;283(48):33437-46. doi: 10.1074/jbc.M802016200. Epub 2008 Oct 1.

16.

Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression.

Moustakas A, Heldin CH.

Cancer Sci. 2007 Oct;98(10):1512-20. Epub 2007 Jul 23. Review.

PMID:
17645776
17.

Epithelial-mesenchymal transition in cancer development and its clinical significance.

Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M.

Cancer Sci. 2010 Feb;101(2):293-9. doi: 10.1111/j.1349-7006.2009.01419.x. Epub 2009 Oct 28. Review.

PMID:
19961486
18.

Regulation of mesenchymal phenotype by MicroRNAs in cancer.

Yan J, Gumireddy K, Li A, Huang Q.

Curr Cancer Drug Targets. 2013 Nov;13(9):930-4. Review.

19.

MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT).

Ding XM.

Chin J Cancer. 2014 Mar;33(3):140-7. doi: 10.5732/cjc.013.10094. Epub 2013 Sep 9. Review.

20.

Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail's pace.

Przybylo JA, Radisky DC.

Int J Biochem Cell Biol. 2007;39(6):1082-8. Epub 2007 Mar 12. Review.

PMID:
17416542
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk